Key cancer-fighting gene's secret weapons revealed

June 11, 2018, Walter and Eliza Hall Institute
Professor Andreas Strasser, associate professor Marco Herold and Dr. Ana Janic from the Walter and Eliza Hall Institute. Credit: The Walter and Eliza Hall Institute

The findings revealed that a special group of genes that function within the body's normal DNA repair process were vital to the effectiveness of p53. This new information could help doctors to better identify patients with an increased risk of developing certain cancers. It could also help to develop safer, more effective treatments for patients.

Dr. Ana Janic, Associate Professor Marco Herold and Professor Andreas Strasser from the Walter and Eliza Hall Institute led the study, published today in Nature Medicine.

Dr. Janic said it was the first time a study had explained how p53 was able to prevent growth.

"In an exciting and unprecedented finding, we discovered that the DNA repair gene MLH1and additional DNA repair genes, are critical to p53's ability to prevent the development of B-cell lymphomas," Dr. Janic said.

Dr. Janic said revealing MLH1 as a powerful weapon for p53 in the fight against cancer could help doctors diagnose patients earlier and prescribe safer, more targeted treatments for their cancer.

"For instance, if a patient has lymphoma with a mutation that disables the DNA repair mechanism, doctors will now know to avoid certain DNA-damaging treatments, such as chemotherapy, that may only make the cancer more aggressive.

"Now that we understand the significance of MLH1 and other DNA repair factors, we can begin to find ways of identifying the vulnerabilities that their loss may impose on cancer cells with the aim of exploiting these for therapeutic benefit," Dr. Janic said.

Dr. Herold said the findings demonstrated the importance of conducting detailed functional analyses. "We screened more than 300 downstream targets of p53 in order to identify which genes were important to p53's tumour-suppressing function.

"It was amazing to find that the loss of the DNA repair gene MLH1 prevented p53 from functioning properly, causing the development of lymphoma. And when MLH1 was put back into the equation, tumour development was significantly stalled.

"This led us to explore other DNA repair genes and it has become clear just how important the whole DNA repair mechanism is to p53's ability to prevent cancer development," Dr. Herold said.

Professor Strasser said understanding how p53 worked was a 'holy grail' for cancer researchers.

"Half of all cancers in the world occur as a result of p53 not functioning as it should. Researchers have long been aware of the significance of p53, but despite many studies, no one has been able to explain how the protein is able to block cancer development until now.

"We are planning to continue our studies into the genes that are regulated by p53, digging deeper into understanding other potential processes that might impact its function," Professor Strasser said.

Dr. Janic said the next steps were to see if the DNA repair process had the same cancer-blocking impact on cancers other than lymphoma, such as pancreatic and colon cancers.

"p53 is mutated in close to 70 percent of colon and pancreatic cancers, so this discovery could have a significant impact on understanding these diseases. We are therefore keen to test whether involved in the DNA process might also play a role in helping p53 prevent the of these cancers," she said.

Explore further: Research reveals cancer-suppressing protein 'multitasks'

More information: DNA repair processes are critical mediators of p53-dependent tumor suppression, Nature Medicine (2018). DOI: 10.1038/s41591-018-0043-5 , https://www.nature.com/articles/s41591-018-0043-5

Related Stories

Research reveals cancer-suppressing protein 'multitasks'

May 9, 2013
The understanding of how a powerful protein called p53 protects against cancer development has been upended by a discovery by Walter and Eliza Hall Institute researchers.

Genetic fixer-uppers may predict bladder cancer prognosis

May 15, 2018
Mutations in genes that help repair damage to DNA may aid in predicting the prognosis of patients with bladder and other related cancers, according to researchers.

Discovery suggests better way to treat certain prostate cancers, lymphomas

November 10, 2017
Certain prostate cancers and lymphomas have a major genetic weakness that doctors can exploit to help save patients' lives, researchers at the University of Virginia School of Medicine have discovered.

Understanding how leukemia and lymphoma cells resist treatment

April 12, 2018
In a study published in Nature Communications, a team led IRCM Hematopoiesis and Cancer Research Unit director Tarik Möröy reveals how the GFI1 protein sometimes helps leukemia and lymphoma cancer cells evade therapy. This ...

Enzyme that regulates DNA repair may offer new precision treatments for breast and ovarian cancer

December 12, 2016
Researchers at Mayo Clinic have identified an enzyme called UCHL3 that regulates the BRCA2 pathway, which is important for DNA repair. Results of this research are published online in Genes & Development.

FDA approves cancer drug for personalized immunotherapy approach

May 26, 2017
Earlier this week, for the first time, a drug was FDA-approved for cancer based on disease genetics rather than type.

Recommended for you

Biologists discover how pancreatic tumors lead to weight loss

June 20, 2018
Patients with pancreatic cancer usually experience significant weight loss, which can begin very early in the disease. A new study from MIT and Dana-Farber Cancer Institute offers insight into how this happens, and suggests ...

Shared genetics may shape treatment options for certain brain disorders

June 20, 2018
Symptoms of schizophrenia and bipolar disorder, including psychosis, depression and manic behavior, have both shared and distinguishing genetic factors, an international consortium led by researchers from Vanderbilt University ...

Researchers find 11 genes responsible for the spread of cancer

June 20, 2018
A groundbreaking discovery by University of Alberta researchers has identified previously-unknown therapeutic targets that could be key to preventing the spread of cancer.

Simple sugar delays neurodegeneration caused by enzyme deficiency

June 20, 2018
A new therapeutic approach may one day delay neurodegeneration typical of a disease called mucopolysaccharidoses IIIB (MPS IIIB). Neurodegeneration in this condition results from the abnormal accumulation of essential cellular ...

Scientists unravel DNA code behind rare neurologic disease

June 20, 2018
Scientists conducting one of the largest full DNA analyses of a rare disease have identified a gene mutation associated with a perplexing brain condition that blinds and paralyzes patients.

'Kiss of death' cancer: How computational geeks may have uncovered a therapy for a deadly disease

June 19, 2018
It's called the 'kiss of death'. Triple negative breast cancer has no targeted drug therapy and, as such, the only hope for these patients is chemotherapy. Triple negative breast cancer is aggressive and deadly. Patients ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.